SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001571049-17-003561
Filing Date
2017-04-13
Accepted
2017-04-13 16:39:44
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13D t1700951_sc13da.htm SC 13D/A 59259
2 EXHIBIT 99.1 t1700951_ex99-1.htm EX-99.1 21547
  Complete submission text file 0001571049-17-003561.txt   82232
Mailing Address 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address 4452 BELTWAY DRIVE ADDISON TX 75001 214-905-5145
ULURU Inc. (Subject) CIK: 0001168220 (see all company filings)

IRS No.: 412118656 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-79412 | Film No.: 17761055
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WIGGIN AND DANA LLP ATTN: SCOTT KAUFMAN, 450 LEXINGTON AVE. NEW YORK NY 10017
Business Address
Sacks Michael Ivan (Filed by) CIK: 0001598785 (see all company filings)

Type: SC 13D/A